Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication July 20, 2012
- Accepted for publication October 4, 2012
- Published online December 28, 2012.
Article Versions
- Earlier version (December 14, 2012 - 09:30).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2013 by the American Society of Nephrology
Author Information
- Julia J. Scialla*,
- Brad C. Astor†‡§,
- Tamara Isakova*,
- Huiliang Xie‖,
- Lawrence J. Appel§¶ and
- Myles Wolf*
- *Division of Nephrology and Hypertension, Department of Medicine and
- ‖Division of Biostatistics, Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, Florida;
- Departments of †Medicine and
- ‡Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; and
- §Welch Center for Prevention, Epidemiology, and Clinical Research and
- ¶Department of Medicine, Johns Hopkins University, Baltimore, Maryland
- Correspondence:
Dr. Myles Wolf, 1120 NW 14th Street, CRB 819, Miami, FL 33136. Email: mwolf2{at}med.miami.edu
Statistics from Altmetric.com
Article usage
Cited By...
In this issue
Mineral Metabolites and CKD Progression in African Americans
Jump to section
More in this TOC Section
Cited By...
- Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study
- Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
- Association of Serum Phosphorus Concentration with Mortality and Graft Failure among Kidney Transplant Recipients
- Fibroblast Growth Factor 23 and Risk of CKD Progression in Children
- Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression
- Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD
- Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study
- From Phosphaturia to Cardiovascular Protection: Is Fibroblast Growth Factor-23 the Heart of the Matter?
- The National Institute of Diabetes and Digestive and Kidney Diseases Central Repositories: A Valuable Resource for Nephrology Research
- Competitive Interaction Between Fibroblast Growth Factor 23 And Asymmetric Dimethylarginine in Patients With CKD
- Fibroblast Growth Factor 23 and Incident CKD in Type 2 Diabetes
- Serum Fibroblast Growth Factor-23 Is Associated with Incident Kidney Disease
- The Biomarker Niche for Fibroblast Growth Factor 23 Testing in CKD
- Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study
- The Use of Fibroblast Growth Factor 23 Testing in Patients with Kidney Disease
- A Within-Patient Analysis for Time-Varying Risk Factors of CKD Progression
- Disordered FGF23 and Mineral Metabolism in Children with CKD
- High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III
- Fibroblast Growth Factor-23 and Cardiovascular Events in CKD